A novel poly(l-glutamic acid) dendrimer based drug delivery system with both pH-sensitive and targeting functions.
The functionalization of pH-sensitiveness and cellular targeting is a promising strategy to fabricate drug delivery systems with high efficiency, high selectivity and low toxicity. In this paper, a poly(l-glutamic acid) dendrimer based drug delivery system with both pH-sensitive and targeting functions is reported. Poly(l-glutamic acid) dendrimers with a polyhedral oligomeric silsesquioxane (POSS) nanocubic core were synthesized. Its globular morphology and compact structure with multiple peripheral functional groups made it suitable for drug delivery. The OAS-G(3)-Glu dendrimer was conjugated with doxorubicin via pH-sensitive hydrazine bonds and targeting moiety (biotin). The cellular internalization and antitumor effects of the conjugates was evaluated in vitro. Both DLS and TEM results indicated that the conjugates aggregated into nanoparticles with diameters around 50 nm. The release rates of doxorubicin at pH 5.0 were much faster than those at pH 7.0 due to the acid cleavage of the hydrazine bonds. The internalization study revealed that the cellular uptake of the biotin modified conjugates was mainly through receptor-mediated endocytosis. These results indicate that our poly(l-glutamic acid) dendrimers with OAS core are promising vectors for fabricating smart and targeting drug delivery systems.
Yuan
Hui
H
National Engineering Research Center for Biomaterials, Sichuan University, Chengdu 610064, China.
Luo
Kui
K
Lai
Yusi
Y
Pu
Yuji
Y
He
Bin
B
Wang
Gang
G
Wu
Yao
Y
Gu
Zhongwei
Z
D050091:Dendrimers / Q000138:chemical synthesis / Q000737:chemistry* / Q000378:metabolism*; D004317:Doxorubicin / Q000008:administration & dosage; D016503:Drug Delivery Systems; D005434:Flow Cytometry; D006367:HeLa Cells; D006801:Humans; D006863:Hydrogen-Ion Concentration; D009682:Magnetic Resonance Spectroscopy; D018613:Microscopy, Confocal; D046529:Microscopy, Electron, Transmission; D008962:Models, Theoretical; D053758:Nanoparticles / Q000737:chemistry / Q000648:ultrastructure; D017646:Organosilicon Compounds / Q000737:chemistry; D011099:Polyglutamic Acid / Q000031:analogs & derivatives*
D050091:Dendrimers; D017646:Organosilicon Compounds; D011099:Polyglutamic Acid; D004317:Doxorubicin